Vivien Veninga, PhD, Analyst, will represent Forbion at the ESMO Congress 2026 from 23–26 October at IFEMA MADRID in Madrid, Spain.
The ESMO Congress is one of the world’s most influential oncology gatherings, bringing together clinicians, researchers, patient advocates and healthcare industry representatives to share the latest advances in oncology research, clinical practice and patient care.
ESMO 2026 provides a leading platform to explore cutting-edge data, connect with experts from across the global oncology community, and engage with the scientific and clinical developments shaping the future of cancer care.